United Therapeutics Corp (UTHR)
274.26
+2.04
(+0.75%)
USD |
NASDAQ |
May 17, 16:00
274.29
+0.03
(+0.01%)
After-Hours: 20:00
United Therapeutics Total Assets (Quarterly): 6.495B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.495B |
December 31, 2023 | 7.167B |
September 30, 2023 | 7.024B |
June 30, 2023 | 6.681B |
March 31, 2023 | 6.346B |
December 31, 2022 | 6.044B |
September 30, 2022 | 5.782B |
June 30, 2022 | 5.543B |
March 31, 2022 | 5.360B |
December 31, 2021 | 5.169B |
September 30, 2021 | 5.049B |
June 30, 2021 | 4.845B |
March 31, 2021 | 4.641B |
December 31, 2020 | 4.615B |
September 30, 2020 | 4.411B |
June 30, 2020 | 4.219B |
March 31, 2020 | 4.026B |
December 31, 2019 | 3.913B |
September 30, 2019 | 4.000B |
June 30, 2019 | 3.899B |
March 31, 2019 | 3.727B |
December 31, 2018 | 3.401B |
September 30, 2018 | 3.412B |
June 30, 2018 | 3.245B |
March 31, 2018 | 3.020B |
Date | Value |
---|---|
December 31, 2017 | 2.879B |
September 30, 2017 | 2.936B |
June 30, 2017 | 2.692B |
March 31, 2017 | 2.561B |
December 31, 2016 | 2.326B |
September 30, 2016 | 2.269B |
June 30, 2016 | 2.202B |
March 31, 2016 | 2.192B |
December 31, 2015 | 2.184B |
September 30, 2015 | 2.159B |
June 30, 2015 | 1.737B |
March 31, 2015 | 1.895B |
December 31, 2014 | 1.884B |
September 30, 2014 | 2.072B |
June 30, 2014 | 1.953B |
March 31, 2014 | 2.115B |
December 31, 2013 | 2.088B |
September 30, 2013 | 1.928B |
June 30, 2013 | 1.778B |
March 31, 2013 | 1.697B |
December 31, 2012 | 1.627B |
September 30, 2012 | 1.647B |
June 30, 2012 | 1.556B |
March 31, 2012 | 1.561B |
December 31, 2011 | 1.518B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.899B
Minimum
Jun 2019
7.167B
Maximum
Dec 2023
5.261B
Average
5.109B
Median
Total Assets (Quarterly) Benchmarks
Liquidia Corp | 197.12M |
Ligand Pharmaceuticals Inc | 913.87M |
Esperion Therapeutics Inc | 373.06M |
Vertex Pharmaceuticals Inc | 23.92B |
ANI Pharmaceuticals Inc | 914.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.157B |
Shareholders Equity (Quarterly) | 5.338B |
Debt to Equity Ratio | 0.1124 |
Current Ratio | 3.775 |
Net Debt Paydown Yield | 0.39% |